Global Pharma Grade Synthetic Camphor Market Poised for Significant Growth, Projected to Reach USD 532.0 Million by 2028

The global pharma grade synthetic camphor market is set to witness substantial expansion in the coming years, with a projected Compound Annual Growth Rate (CAGR) of 4.2% from 2022 to 2028. According to recent forecasts, the market, which was valued at USD 415.4 million in 2022, is expected to soar to an impressive USD 532.0 million by 2028.

This robust growth reflects the rising demand for high-quality synthetic camphor in pharmaceutical applications, driven by its crucial role in a variety of therapeutic and medicinal products. Synthetic camphor is increasingly being adopted in consumer healthcare products, while advancements in manufacturing technologies are further enhancing product quality and efficiency, contributing to the overall market growth.

Industry experts attribute this impressive market trajectory to several key factors, including:

• Rising investments in research and development focused on synthetic camphor’s applications in the pharmaceutical sector.
• Growing awareness of the benefits of synthetic camphor, particularly in ensuring high-purity pharmaceutical ingredients.
• Increased focus on eco-friendly and sustainable production processes, in line with global trends toward greener manufacturing.

“The projected growth of the pharma grade synthetic camphor market underscores its significant role in the pharmaceutical industry,” said a representative from FMI. “As we approach 2028, we anticipate continued innovation and advancements, driving the market to new heights and improving the quality and efficacy of pharmaceutical products globally.”

As the market continues to evolve, stakeholders are encouraged to stay informed about emerging trends and technological advancements to capitalize on growth opportunities and maintain a competitive edge in this dynamic sector.

Key Takeaways: Pharma Grade Synthetic Camphor Market Growth

• The global pharma grade synthetic camphor market is projected to grow at a CAGR of 4.2% from 2022 to 2028, reaching USD 532.0 million by 2028.
• The U.S. leads the North American market due to high product value and profit margins, while Germany dominates the European market with its robust healthcare infrastructure and high prevalence of influenza.
• India commands over 55% of the market share, driven by a high incidence of influenza and market accessibility, while China holds around 13.1% of the market, with expectations of rapid expansion due to rising influenza cases and low vaccination rates.
• The market is also experiencing growing demand for alternative medicines to treat influenza and related illnesses, particularly in high-risk populations like children and the elderly.
• Increased awareness and accessibility of over-the-counter (OTC) products for self-medication are contributing to market growth.

High Demand for Pharma Grade Synthetic Camphor: Uncover the Trends and Insights with Our Detailed Report!

Competitive Landscape:

Manufacturers and integrators are actively expanding their consumer base across various regions by increasing over-the-counter purchases and enhancing product availability through multiple sales channels. Key industry players are also focusing on expanding their brands and technology in emerging markets through strategic partnerships and collaborations to strengthen their market presence.

For instance:

• In January 2017, Merck acquired BioControl Systems Inc., enhancing its position in the food safety testing sector.
• In August 2016, Merck inaugurated a new pharmaceuticals manufacturing plant in Nantong, China, further supporting its expansion in the Chinese market.

Key Companies Profiled:

• Merck KGaA
• Oriental Aromatics Limited
• Saptagir Camphor Limited
• Mangalam Organics Limited
• Nippon Fine Chemical Co., Ltd.
• Rochem International, Inc.
• Spectrum Chemical Mfg. Corp.
• Aldon Corporation
• Prinova Group LLC
• Fengchen Group Co., Ltd.

Market Segmentation:

By Formulation Type:

• Topical
• Inhalation

By Application:

• Respiratory Disorders
• Muscular Rheumatism
• Counterirritant and Antipruritic
• Others

By Distribution Channels:

• Conventional B2B (Tenders, Direct Procurement, Wholesalers & Distributors)
• Online B2B (Internal Channel, External Channel)

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• APECJ
• Japan
• China
• Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube